Recall
FDAHealthOctober 31, 2025

Novocol Pharmaceutical of Canada, Inc. — 3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml

⚠️ Defective container: cracked/broken cartridges

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
October 31, 2025

U.S.A. Nationwide

What's affected?

Product
3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.
Lot code
D05159C

Additional details

Lot: D05159C, expires: 07-31-2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 5,825.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.